We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Arkle Resources Plc | AQSE:ARK.GB | Aquis Stock Exchange | Ordinary Share | IE00B2357X72 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.225 | 0.15 | 0.30 | 0.225 | 0.225 | 0.225 | 0.00 | 06:59:32 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMARK
RNS Number : 8985W
Arkle Resources PLC
15 December 2023
15 December 2023
Arkle Resources PLC
("Arkle" or the "Company")
Award of New Lithium Brines Licences
Highlights
- Two licences awarded in the Makgadikgadi Salt Pans of Botswana - Arkle to begin prospecting for lithium brines in early 2024
Arkle Resources (AIM:ARK) is pleased to announce that it has been awarded two exploration licences in the Makgadikgadi Salt Pans in North Eastern Botswana. The licences, PL 075/2023 and PL 0148/2023, cover 312 and 525 sq kilometres respectively in size.
The licences are awarded to prospect for lithium in the Salt Pans. There is very little known about the potential for lithium brines in the vast Makgadikgadi Salt Pans. Early-stage prospecting work will begin in early 2024.
John Teeling, Chairman, commented : "We are really pleased to have been awarded these two large licences in the Makgadikgadi Salt Pans. We now have three lithium exploration projects, one in Ireland, one in Zimbabwe, both hard rock, and now in Botswana which is a lithium brines project. Initial work will focus on analysis of the very limited exploration data, followed by prospecting to identify targets for drilling."
This announcement has been reviewed and approved by Ben Mosigi in his capacity as the Qualified Person for the purposes of the AIM Note for Mining, Oil and Gas Companies issued by the London Stock Exchange.
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.
Enquiries:
Arkle Resources PLC John Teeling, Chairman +353 (0) 1 833 2833 Jim Finn, Finance Director +353 (0) 1 833 2833 SP Angel Corporate Finance LLP Nominated Adviser & Joint Broker Matthew Johnson/Adam Cowl +44 (0) 203 470 0470 First Equity Limited Joint Broker Jason Robertson +44 (0) 207 374 2212 BlytheRay +44 (0) 207 138 3204 Megan Ray Teneo Luke Hogg +353 (0) 1 661 4055
Information for Editors
Arkle is a diversified exploration company with lithium exploration licences in Ireland, Zimbabwe and Botswana and gold and zinc projects in Ireland.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCBRBDDUDBDGXS
(END) Dow Jones Newswires
December 15, 2023 02:00 ET (07:00 GMT)
1 Year Arkle Resources Chart |
1 Month Arkle Resources Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions